These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9342191)

  • 1. The tumor suppressor gene p53 can mediate transforming growth [corrected] factor beta1-induced differentiation of leukemic cells independently of activation of the retinoblastoma protein.
    Ehinger M; Bergh G; Johnsson E; Gullberg U; Olsson I
    Cell Growth Differ; 1997 Oct; 8(10):1127-37. PubMed ID: 9342191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the molecular mechanisms for p53-mediated differentiation.
    Chylicki K; Ehinger M; Svedberg H; Gullberg U
    Cell Growth Differ; 2000 Nov; 11(11):561-71. PubMed ID: 11095245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells.
    Elbendary A; Berchuck A; Davis P; Havrilesky L; Bast RC; Iglehart JD; Marks JR
    Cell Growth Differ; 1994 Dec; 5(12):1301-7. PubMed ID: 7696178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 dephosphorylation and p21(Cip1/Waf1) translocation correlate with caspase-3 activation in TGF-beta1-induced apoptosis of HuH-7 cells.
    Fan G; Ma X; Wong PY; Rodrigues CM; Steer CJ
    Apoptosis; 2004 Mar; 9(2):211-21. PubMed ID: 15004518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth stimulation of murine fibroblasts by TGF-beta1 depends on the expression of a functional p53 protein.
    Dkhissi F; Raynal S; Jullien P; Lawrence DA
    Oncogene; 1999 Jan; 18(3):703-11. PubMed ID: 9989820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor suppressor proteins as regulators of cell differentiation.
    Li ZR; Hromchak R; Mudipalli A; Bloch A
    Cancer Res; 1998 Oct; 58(19):4282-7. PubMed ID: 9766653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-beta1 induces apoptotic cell death in cultured retinal endothelial cells but not pericytes: association with decreased expression of p21waf1/cip1.
    Yan Q; Sage EH
    J Cell Biochem; 1998 Jul; 70(1):70-83. PubMed ID: 9632109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
    Guo Y; Kyprianou N
    Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of the tumor suppressor gene p53 in tumor necrosis factor-induced differentiation of the leukemic cell line K562.
    Ehinger M; Nilsson E; Persson AM; Olsson I; Gullberg U
    Cell Growth Differ; 1995 Jan; 6(1):9-17. PubMed ID: 7718488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53-mediated differentiation of the erythroleukemia cell line K562.
    Chylicki K; Ehinger M; Svedberg H; Bergh G; Olsson I; Gullberg U
    Cell Growth Differ; 2000 Jun; 11(6):315-24. PubMed ID: 10910098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of growth arrest by p16INK4, p21WAF1, pRB, and p53 is dependent on the integrity of the endogenous cell-cycle control pathways in human glioblastoma cell lines.
    Costanzi-Strauss E; Strauss BE; Naviaux RK; Haas M
    Exp Cell Res; 1998 Jan; 238(1):51-62. PubMed ID: 9457056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damage.
    Kelley LL; Hicks GG; Hsieh FF; Prasher JM; Green WF; Miller MD; Eide EJ; Ruley HE
    Oncogene; 1998 Sep; 17(9):1119-30. PubMed ID: 9764822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Butyrate-induced G1 arrest results from p21-independent disruption of retinoblastoma protein-mediated signals.
    Vaziri C; Stice L; Faller DV
    Cell Growth Differ; 1998 Jun; 9(6):465-74. PubMed ID: 9663465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells.
    Cartee L; Wang Z; Decker RH; Chellappan SP; Fusaro G; Hirsch KG; Sankala HM; Dent P; Grant S
    Cancer Res; 2001 Mar; 61(6):2583-91. PubMed ID: 11289135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53-dependent and -independent differentiation of leukemic U-937 cells: relationship to cell cycle control.
    Ehinger M; Bergh G; Johnsson E; Baldetorp B; Olsson I; Gullberg U
    Exp Hematol; 1998 Oct; 26(11):1043-52. PubMed ID: 9766444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional interplay between p53 and E2F through co-activator p300.
    Lee CW; Sørensen TS; Shikama N; La Thangue NB
    Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD30-mediated cell cycle arrest associated with induced expression of p21(CIP1/WAF1) in the anaplastic large cell lymphoma cell line Karpas 299.
    Hübinger G; Müller E; Scheffrahn I; Schneider C; Hildt E; Singer BB; Sigg I; Graf J; Bergmann L
    Oncogene; 2001 Feb; 20(5):590-8. PubMed ID: 11313991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF1 1.
    Rosato RR; Almenara JA; Grant S
    Cancer Res; 2003 Jul; 63(13):3637-45. PubMed ID: 12839953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The induction of apoptosis by a combined 1,25(OH)2D3 analog, EB1089 and TGF-beta1 in NCI-H929 multiple myeloma cells.
    Park WH; Seol JG; Kim ES; Binderup L; Koeffler HP; Kim BK; Lee YY
    Int J Oncol; 2002 Mar; 20(3):533-42. PubMed ID: 11836565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell cycle gene regulation in reversibly differentiated new human hepatoma cell lines.
    Glaise D; Ilyin GP; Loyer P; Cariou S; Bilodeau M; Lucas J; Puisieux A; Ozturk M; Guguen-Guillouzo C
    Cell Growth Differ; 1998 Feb; 9(2):165-76. PubMed ID: 9486853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.